Clinical pharmacokinetics of amifostine and WR1065 in pediatric patients with medulloblastoma. [PDF]
Clin Cancer Res, 2010 McKibbin T +6 more
europepmc +1 more source
WR-1065, the active metabolite of amifostine, mitigates radiation-induced delayed genomic instability. [PDF]
Free Radic Biol Med, 2008 Dziegielewski J +7 more
europepmc +1 more source
Effect of North American ginseng on 137Cs-induced micronuclei in human lymphocytes: a comparison with WR-1065. [PDF]
Phytother Res, 2008 Lee TK +6 more
europepmc +1 more source
Comments on the mechanisms of action of radiation protective agents: basis components and their polyvalence. [PDF]
Springerplus, 2014 Vasin MV.
europepmc +1 more source
WR1065 mitigates AZT-ddI-induced mutagenesis and inhibits viral replication. [PDF]
Environ Mol Mutagen, 2009 Walker DM +11 more
europepmc +1 more source
COMPUTATIONAL APPROACH ON CHEMICAL REACTIVITY OF BETA-MERCAPTOETHYLAMINE
INTERNATIONAL JOURNAL OF ADVANCED SCIENTIFIC AND TECHNICAL RESEARCH, 2020 K. RAJALAKSHMI, M. VETRIVEL
openaire +1 more source
Mammalian cell polyamine homeostasis is altered by the radioprotector WR1065. [PDF]
Biochem J, 1998 Mitchell JL +3 more
europepmc +1 more source
Delayed radioprotection by nuclear transcription factor kappaB -mediated induction of manganese superoxide dismutase in human microvascular endothelial cells after exposure to the free radical scavenger WR1065. [PDF]
Free Radic Biol Med, 2006 Murley JS +4 more
europepmc +1 more source
WR-1065, an active metabolite of the cytoprotector amifostine, affects phosphorylation of topoisomerase II alpha leading to changes in enzyme activity and cell cycle progression in CHO AA8 cells. [PDF]
Cell Prolif, 1997 Murley JS +3 more
europepmc +1 more source